Author Question: When discussing the risks of obesity with a client, the nurse should discuss that the underlying ... (Read 28 times)

captainjonesify

  • Hero Member
  • *****
  • Posts: 543
When discussing the risks of obesity with a client, the nurse should discuss that the underlying risk factors for metabolic syndrome are:
 
  1. Diabetes and elevated blood sugar.
   2. Obesity and inactivity.
   3. Hypertension and lack of exercise.
   4. Abdominal fat and hypertension.

Question 2

A student in a nutrition class is giving a report on Adolescent Obesity. One of the topics in the report is health risks increased by obesity. What health risk would you expect to be included in the report?
 
  A) Hypercalcemia C) Hypercholesterolemi a
  B) Type 1 diabetes mellitus D) Hyperlipidemia



kardosa007

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

2
Rationale: Poorly controlled diabetes is a risk factor for end organ damage including cardiovascular disease (CVD). Obesity and inactivity are the underlying risk factors for metabolic syndrome. Hypertension, lack of exercise, and buildup of abdominal fat are all risks of CVD.

Answer to Question 2

D
Feedback:
Obese children and adolescents are developing complications of excess weight seen in adults, such as prediabetes, diabetes, hypertension, and hyperlipidemia.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

Eat fiber! A diet high in fiber can help lower cholesterol levels by as much as 10%.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library